HomeInsightsStock Comparison

Astonea Labs Ltd vs Sanofi India Ltd Stock Comparison

Astonea Labs Ltd vs Sanofi India Ltd Stock Comparison

Last Updated on: Jun 18, 2025

Key Highlights

  • The Latest Trading Price of Astonea Labs Ltd is ₹ 148.5 as of 18 Jun 11:23.
  • The P/E Ratio of Astonea Labs Ltd is 0 as of December 2023 .The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023.
  • The Market Cap of Astonea Labs Ltd is ₹ 0 crore as of December 2023 .The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023.
  • The revenue of Astonea Labs Ltd for the Mar '24 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sanofi India Ltd for the Mar '24 is ₹ 528.8 crore as compare to the Dec '24 revenue of ₹ 526.3 crore. This represent the growth of 0.48%.
  • The ebitda of Astonea Labs Ltd for the Mar '24 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi India Ltd for the Mar '24 is ₹ 132.2 crore as compare to the Dec '24 ebitda of ₹ 122 crore. This represent the growth of 8.36%.
  • The net profit of Astonea Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sanofi India Ltd changed from ₹ 190.4 crore to ₹ 91.3 crore over 7 quarters. This represents a CAGR of -34.29% .
  • The dividend payout of Astonea Labs Ltd changed from 0 % to 0 % over 8 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi India Ltd changed from 175.77 % to 0 % over 8 quarters. This represents a CAGR of -100.00% .

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astonea Labs Ltd

  • Astonea Labs Ltd was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
  • Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
  • Subsequently, the Company converted into 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
  • These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
  • These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

About Sanofi India Ltd

  • Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
  • The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
  • The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
  • The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
  • It has its own manufacturing facility at Goa.

Astonea Labs Ltd News Hub

News

BSE SME Astonea Labs inches higher on debut

The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public off...

Read more

03 Jun 2025 11:01

Sanofi India Ltd News Hub

News

Sanofi India to hold board meeting

Sanofi India will hold a meeting of the Board of Directors of the Company on 14 May 2025. ...

Read more

10 May 2025 10:52

News

Sanofi India MD Rodolfo Hrosz resigns

The board of directors accepted Hrosz's resignation during a meeting held on 9 April and e...

Read more

11 Apr 2025 11:01

News

Sanofi India to convene AGM

Sanofi India announced that the 69th Annual General Meeting(AGM) of the company will be he...

Read more

19 Mar 2025 12:01

News

Board of Sanofi India recommends final dividend

Sanofi India announced that the Board of Directors of the Company at its meeting held on 2...

Read more

28 Feb 2025 09:13

News

Board of Schaeffler India recommends Final Dividend

Schaeffler India announced that the Board of Directors of the Company at its meeting held ...

Read more

27 Feb 2025 17:28

News

Sanofi India to conduct board meeting

Sanofi India will hold a meeting of the Board of Directors of the Company on 27 February 2...

Read more

14 Feb 2025 09:41

SWOT Analysis Of Sanofi India Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sanofi India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Sanofi India Ltd

Which company has a larger market capitalization, Astonea Labs Ltd or Sanofi India Ltd?

Market cap of Astonea Labs Ltd is 149 Cr while Market cap of Sanofi India Ltd is 13,948 Cr

What are the key factors driving the stock performance of Astonea Labs Ltd and Sanofi India Ltd?

The stock performance of Astonea Labs Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astonea Labs Ltd and Sanofi India Ltd?

As of June 18, 2025, the Astonea Labs Ltd stock price is INR ₹142.35. On the other hand, Sanofi India Ltd stock price is INR ₹6056.6.

How do dividend payouts of Astonea Labs Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Astonea Labs Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions